Deficiency of Fyn protein is prerequisite for apoptosis induced by Src family kinase inhibitors in human mesothelioma cells

Fyn

(2010) Yoshihito D. Saito et al.   CANCER

LYN Is a Mediator of Epithelial-Mesenchymal Transition and a Target of Dasatinib in Breast Cancer

(2010) Y.-L. Choi et al.   CANCER RESEARCH

The role of enoyl-CoA hydratase short chain 1 and peroxiredoxin 3 in PP2-induced apoptosis in human breast cancer MCF-7 cells

(2010) Xiang Liu et al.   FEBS LETTERS

Arsenic trioxide induces apoptosis through JNK and ERK in human mesothelioma cells

(2010) Ryoji Eguchi et al.   JOURNAL OF CELLULAR PHYSIOLOGY

A chemical and phosphoproteomic characterization of dasatinib action in lung cancer

(2010) Jiannong Li et al.   Nature Chemical Biology

Dasatinib treatment for Philadelphia chromosome-positive leukemias

(2009) Hanna Jean Khoury et al.   CANCER

Multiple roles of Lyn kinase in myeloid cell signaling and function

(2009) Patrizia Scapini et al.   IMMUNOLOGICAL REVIEWS

Malignant Pleural Mesothelioma

(2009) Anne S. Tsao et al.   JOURNAL OF CLINICAL ONCOLOGY

Gene expression profiling of imatinib and PD166326-resistant CML cell lines identifies Fyn as a gene associated with resistance to BCR-ABL inhibitors

(2009) S. Grosso et al.   MOLECULAR CANCER THERAPEUTICS

BCR-ABL1 mediates up-regulation of Fyn in chronic myelogenous leukemia

(2008) K. Ban et al.   BLOOD

Chemotherapy for malignant pleural mesothelioma

(2008) Nicholas J Vogelzang   LANCET